Search

Your search keyword '"Furuse, Junji"' showing total 45 results
Start Over Author "Furuse, Junji" Publisher american association for cancer research (aacr)
45 results on '"Furuse, Junji"'

24. Supplementary Figure 2 from Phase I Trial of a Glypican-3–Derived Peptide Vaccine for Advanced Hepatocellular Carcinoma: Immunologic Evidence and Potential for Improving Overall Survival

Author

Sawada, Yu, primary, Yoshikawa, Toshiaki, primary, Nobuoka, Daisuke, primary, Shirakawa, Hirofumi, primary, Kuronuma, Toshimitsu, primary, Motomura, Yutaka, primary, Mizuno, Shoichi, primary, Ishii, Hiroshi, primary, Nakachi, Kohei, primary, Konishi, Masaru, primary, Nakagohri, Toshio, primary, Takahashi, Shinichiro, primary, Gotohda, Naoto, primary, Takayama, Tadatoshi, primary, Yamao, Kenji, primary, Uesaka, Katsuhiko, primary, Furuse, Junji, primary, Kinoshita, Taira, primary, and Nakatsura, Tetsuya, primary

Published
2023
Full Text
View/download PDF

25. Table S3 from Rb Loss and KRAS Mutation Are Predictors of the Response to Platinum-Based Chemotherapy in Pancreatic Neuroendocrine Neoplasm with Grade 3: A Japanese Multicenter Pancreatic NEN-G3 Study

Author

Hijioka, Susumu, primary, Hosoda, Waki, primary, Matsuo, Keitaro, primary, Ueno, Makoto, primary, Furukawa, Masayuki, primary, Yoshitomi, Hideyuki, primary, Kobayashi, Noritoshi, primary, Ikeda, Masafumi, primary, Ito, Tetsuhide, primary, Nakamori, Shoji, primary, Ishii, Hiroshi, primary, Kodama, Yuzo, primary, Morizane, Chigusa, primary, Okusaka, Takuji, primary, Yanagimoto, Hiroaki, primary, Notohara, Kenji, primary, Taguchi, Hiroki, primary, Kitano, Masayuki, primary, Yane, Kei, primary, Maguchi, Hiroyuki, primary, Tsuchiya, Yoshiaki, primary, Komoto, Izumi, primary, Tanaka, Hiroki, primary, Tsuji, Akihito, primary, Hashigo, Syunpei, primary, Kawaguchi, Yoshiaki, primary, Mine, Tetsuya, primary, Kanno, Atsushi, primary, Murohisa, Go, primary, Miyabe, Katsuyuki, primary, Takagi, Tadayuki, primary, Matayoshi, Nobutaka, primary, Yoshida, Tsukasa, primary, Hara, Kazuo, primary, Imamura, Masayuki, primary, Furuse, Junji, primary, Yatabe, Yasushi, primary, and Mizuno, Nobumasa, primary

Published
2023
Full Text
View/download PDF

26. Supplementary Figure 1 from Phase I Trial of a Glypican-3–Derived Peptide Vaccine for Advanced Hepatocellular Carcinoma: Immunologic Evidence and Potential for Improving Overall Survival

Author

Sawada, Yu, primary, Yoshikawa, Toshiaki, primary, Nobuoka, Daisuke, primary, Shirakawa, Hirofumi, primary, Kuronuma, Toshimitsu, primary, Motomura, Yutaka, primary, Mizuno, Shoichi, primary, Ishii, Hiroshi, primary, Nakachi, Kohei, primary, Konishi, Masaru, primary, Nakagohri, Toshio, primary, Takahashi, Shinichiro, primary, Gotohda, Naoto, primary, Takayama, Tadatoshi, primary, Yamao, Kenji, primary, Uesaka, Katsuhiko, primary, Furuse, Junji, primary, Kinoshita, Taira, primary, and Nakatsura, Tetsuya, primary

Published
2023
Full Text
View/download PDF

27. Table S2 from Rb Loss and KRAS Mutation Are Predictors of the Response to Platinum-Based Chemotherapy in Pancreatic Neuroendocrine Neoplasm with Grade 3: A Japanese Multicenter Pancreatic NEN-G3 Study

Author

Hijioka, Susumu, primary, Hosoda, Waki, primary, Matsuo, Keitaro, primary, Ueno, Makoto, primary, Furukawa, Masayuki, primary, Yoshitomi, Hideyuki, primary, Kobayashi, Noritoshi, primary, Ikeda, Masafumi, primary, Ito, Tetsuhide, primary, Nakamori, Shoji, primary, Ishii, Hiroshi, primary, Kodama, Yuzo, primary, Morizane, Chigusa, primary, Okusaka, Takuji, primary, Yanagimoto, Hiroaki, primary, Notohara, Kenji, primary, Taguchi, Hiroki, primary, Kitano, Masayuki, primary, Yane, Kei, primary, Maguchi, Hiroyuki, primary, Tsuchiya, Yoshiaki, primary, Komoto, Izumi, primary, Tanaka, Hiroki, primary, Tsuji, Akihito, primary, Hashigo, Syunpei, primary, Kawaguchi, Yoshiaki, primary, Mine, Tetsuya, primary, Kanno, Atsushi, primary, Murohisa, Go, primary, Miyabe, Katsuyuki, primary, Takagi, Tadayuki, primary, Matayoshi, Nobutaka, primary, Yoshida, Tsukasa, primary, Hara, Kazuo, primary, Imamura, Masayuki, primary, Furuse, Junji, primary, Yatabe, Yasushi, primary, and Mizuno, Nobumasa, primary

Published
2023
Full Text
View/download PDF

28. Supplementary Figure Legend from Phase I Trial of a Glypican-3–Derived Peptide Vaccine for Advanced Hepatocellular Carcinoma: Immunologic Evidence and Potential for Improving Overall Survival

Author

Sawada, Yu, primary, Yoshikawa, Toshiaki, primary, Nobuoka, Daisuke, primary, Shirakawa, Hirofumi, primary, Kuronuma, Toshimitsu, primary, Motomura, Yutaka, primary, Mizuno, Shoichi, primary, Ishii, Hiroshi, primary, Nakachi, Kohei, primary, Konishi, Masaru, primary, Nakagohri, Toshio, primary, Takahashi, Shinichiro, primary, Gotohda, Naoto, primary, Takayama, Tadatoshi, primary, Yamao, Kenji, primary, Uesaka, Katsuhiko, primary, Furuse, Junji, primary, Kinoshita, Taira, primary, and Nakatsura, Tetsuya, primary

Published
2023
Full Text
View/download PDF

29. Supplementary Figure Legend from Phase I Trial of a Glypican-3–Derived Peptide Vaccine for Advanced Hepatocellular Carcinoma: Immunologic Evidence and Potential for Improving Overall Survival

Author

Sawada, Yu, primary, Yoshikawa, Toshiaki, primary, Nobuoka, Daisuke, primary, Shirakawa, Hirofumi, primary, Kuronuma, Toshimitsu, primary, Motomura, Yutaka, primary, Mizuno, Shoichi, primary, Ishii, Hiroshi, primary, Nakachi, Kohei, primary, Konishi, Masaru, primary, Nakagohri, Toshio, primary, Takahashi, Shinichiro, primary, Gotohda, Naoto, primary, Takayama, Tadatoshi, primary, Yamao, Kenji, primary, Uesaka, Katsuhiko, primary, Furuse, Junji, primary, Kinoshita, Taira, primary, and Nakatsura, Tetsuya, primary

Published
2023
Full Text
View/download PDF

30. Table S1 from Rb Loss and KRAS Mutation Are Predictors of the Response to Platinum-Based Chemotherapy in Pancreatic Neuroendocrine Neoplasm with Grade 3: A Japanese Multicenter Pancreatic NEN-G3 Study

Author

Hijioka, Susumu, primary, Hosoda, Waki, primary, Matsuo, Keitaro, primary, Ueno, Makoto, primary, Furukawa, Masayuki, primary, Yoshitomi, Hideyuki, primary, Kobayashi, Noritoshi, primary, Ikeda, Masafumi, primary, Ito, Tetsuhide, primary, Nakamori, Shoji, primary, Ishii, Hiroshi, primary, Kodama, Yuzo, primary, Morizane, Chigusa, primary, Okusaka, Takuji, primary, Yanagimoto, Hiroaki, primary, Notohara, Kenji, primary, Taguchi, Hiroki, primary, Kitano, Masayuki, primary, Yane, Kei, primary, Maguchi, Hiroyuki, primary, Tsuchiya, Yoshiaki, primary, Komoto, Izumi, primary, Tanaka, Hiroki, primary, Tsuji, Akihito, primary, Hashigo, Syunpei, primary, Kawaguchi, Yoshiaki, primary, Mine, Tetsuya, primary, Kanno, Atsushi, primary, Murohisa, Go, primary, Miyabe, Katsuyuki, primary, Takagi, Tadayuki, primary, Matayoshi, Nobutaka, primary, Yoshida, Tsukasa, primary, Hara, Kazuo, primary, Imamura, Masayuki, primary, Furuse, Junji, primary, Yatabe, Yasushi, primary, and Mizuno, Nobumasa, primary

Published
2023
Full Text
View/download PDF

31. Supplementary Figure Legend from Rb Loss and KRAS Mutation Are Predictors of the Response to Platinum-Based Chemotherapy in Pancreatic Neuroendocrine Neoplasm with Grade 3: A Japanese Multicenter Pancreatic NEN-G3 Study

Author

Hijioka, Susumu, primary, Hosoda, Waki, primary, Matsuo, Keitaro, primary, Ueno, Makoto, primary, Furukawa, Masayuki, primary, Yoshitomi, Hideyuki, primary, Kobayashi, Noritoshi, primary, Ikeda, Masafumi, primary, Ito, Tetsuhide, primary, Nakamori, Shoji, primary, Ishii, Hiroshi, primary, Kodama, Yuzo, primary, Morizane, Chigusa, primary, Okusaka, Takuji, primary, Yanagimoto, Hiroaki, primary, Notohara, Kenji, primary, Taguchi, Hiroki, primary, Kitano, Masayuki, primary, Yane, Kei, primary, Maguchi, Hiroyuki, primary, Tsuchiya, Yoshiaki, primary, Komoto, Izumi, primary, Tanaka, Hiroki, primary, Tsuji, Akihito, primary, Hashigo, Syunpei, primary, Kawaguchi, Yoshiaki, primary, Mine, Tetsuya, primary, Kanno, Atsushi, primary, Murohisa, Go, primary, Miyabe, Katsuyuki, primary, Takagi, Tadayuki, primary, Matayoshi, Nobutaka, primary, Yoshida, Tsukasa, primary, Hara, Kazuo, primary, Imamura, Masayuki, primary, Furuse, Junji, primary, Yatabe, Yasushi, primary, and Mizuno, Nobumasa, primary

Published
2023
Full Text
View/download PDF

32. Supplementary Figure 2 from Phase I Trial of a Glypican-3–Derived Peptide Vaccine for Advanced Hepatocellular Carcinoma: Immunologic Evidence and Potential for Improving Overall Survival

Author

Sawada, Yu, primary, Yoshikawa, Toshiaki, primary, Nobuoka, Daisuke, primary, Shirakawa, Hirofumi, primary, Kuronuma, Toshimitsu, primary, Motomura, Yutaka, primary, Mizuno, Shoichi, primary, Ishii, Hiroshi, primary, Nakachi, Kohei, primary, Konishi, Masaru, primary, Nakagohri, Toshio, primary, Takahashi, Shinichiro, primary, Gotohda, Naoto, primary, Takayama, Tadatoshi, primary, Yamao, Kenji, primary, Uesaka, Katsuhiko, primary, Furuse, Junji, primary, Kinoshita, Taira, primary, and Nakatsura, Tetsuya, primary

Published
2023
Full Text
View/download PDF

33. Supplementary Table 2 from Phase I Trial of a Glypican-3–Derived Peptide Vaccine for Advanced Hepatocellular Carcinoma: Immunologic Evidence and Potential for Improving Overall Survival

Author

Sawada, Yu, primary, Yoshikawa, Toshiaki, primary, Nobuoka, Daisuke, primary, Shirakawa, Hirofumi, primary, Kuronuma, Toshimitsu, primary, Motomura, Yutaka, primary, Mizuno, Shoichi, primary, Ishii, Hiroshi, primary, Nakachi, Kohei, primary, Konishi, Masaru, primary, Nakagohri, Toshio, primary, Takahashi, Shinichiro, primary, Gotohda, Naoto, primary, Takayama, Tadatoshi, primary, Yamao, Kenji, primary, Uesaka, Katsuhiko, primary, Furuse, Junji, primary, Kinoshita, Taira, primary, and Nakatsura, Tetsuya, primary

Published
2023
Full Text
View/download PDF

34. Supplementary Table 1 from Phase I Trial of a Glypican-3–Derived Peptide Vaccine for Advanced Hepatocellular Carcinoma: Immunologic Evidence and Potential for Improving Overall Survival

Author

Sawada, Yu, primary, Yoshikawa, Toshiaki, primary, Nobuoka, Daisuke, primary, Shirakawa, Hirofumi, primary, Kuronuma, Toshimitsu, primary, Motomura, Yutaka, primary, Mizuno, Shoichi, primary, Ishii, Hiroshi, primary, Nakachi, Kohei, primary, Konishi, Masaru, primary, Nakagohri, Toshio, primary, Takahashi, Shinichiro, primary, Gotohda, Naoto, primary, Takayama, Tadatoshi, primary, Yamao, Kenji, primary, Uesaka, Katsuhiko, primary, Furuse, Junji, primary, Kinoshita, Taira, primary, and Nakatsura, Tetsuya, primary

Published
2023
Full Text
View/download PDF

35. Supplementary Table 2 from Phase I Trial of a Glypican-3–Derived Peptide Vaccine for Advanced Hepatocellular Carcinoma: Immunologic Evidence and Potential for Improving Overall Survival

Author

Sawada, Yu, primary, Yoshikawa, Toshiaki, primary, Nobuoka, Daisuke, primary, Shirakawa, Hirofumi, primary, Kuronuma, Toshimitsu, primary, Motomura, Yutaka, primary, Mizuno, Shoichi, primary, Ishii, Hiroshi, primary, Nakachi, Kohei, primary, Konishi, Masaru, primary, Nakagohri, Toshio, primary, Takahashi, Shinichiro, primary, Gotohda, Naoto, primary, Takayama, Tadatoshi, primary, Yamao, Kenji, primary, Uesaka, Katsuhiko, primary, Furuse, Junji, primary, Kinoshita, Taira, primary, and Nakatsura, Tetsuya, primary

Published
2023
Full Text
View/download PDF

36. Supplementary Figure 1 from Phase I Trial of a Glypican-3–Derived Peptide Vaccine for Advanced Hepatocellular Carcinoma: Immunologic Evidence and Potential for Improving Overall Survival

Author

Sawada, Yu, primary, Yoshikawa, Toshiaki, primary, Nobuoka, Daisuke, primary, Shirakawa, Hirofumi, primary, Kuronuma, Toshimitsu, primary, Motomura, Yutaka, primary, Mizuno, Shoichi, primary, Ishii, Hiroshi, primary, Nakachi, Kohei, primary, Konishi, Masaru, primary, Nakagohri, Toshio, primary, Takahashi, Shinichiro, primary, Gotohda, Naoto, primary, Takayama, Tadatoshi, primary, Yamao, Kenji, primary, Uesaka, Katsuhiko, primary, Furuse, Junji, primary, Kinoshita, Taira, primary, and Nakatsura, Tetsuya, primary

Published
2023
Full Text
View/download PDF

37. FigureS1 from Rb Loss and KRAS Mutation Are Predictors of the Response to Platinum-Based Chemotherapy in Pancreatic Neuroendocrine Neoplasm with Grade 3: A Japanese Multicenter Pancreatic NEN-G3 Study

Author

Hijioka, Susumu, primary, Hosoda, Waki, primary, Matsuo, Keitaro, primary, Ueno, Makoto, primary, Furukawa, Masayuki, primary, Yoshitomi, Hideyuki, primary, Kobayashi, Noritoshi, primary, Ikeda, Masafumi, primary, Ito, Tetsuhide, primary, Nakamori, Shoji, primary, Ishii, Hiroshi, primary, Kodama, Yuzo, primary, Morizane, Chigusa, primary, Okusaka, Takuji, primary, Yanagimoto, Hiroaki, primary, Notohara, Kenji, primary, Taguchi, Hiroki, primary, Kitano, Masayuki, primary, Yane, Kei, primary, Maguchi, Hiroyuki, primary, Tsuchiya, Yoshiaki, primary, Komoto, Izumi, primary, Tanaka, Hiroki, primary, Tsuji, Akihito, primary, Hashigo, Syunpei, primary, Kawaguchi, Yoshiaki, primary, Mine, Tetsuya, primary, Kanno, Atsushi, primary, Murohisa, Go, primary, Miyabe, Katsuyuki, primary, Takagi, Tadayuki, primary, Matayoshi, Nobutaka, primary, Yoshida, Tsukasa, primary, Hara, Kazuo, primary, Imamura, Masayuki, primary, Furuse, Junji, primary, Yatabe, Yasushi, primary, and Mizuno, Nobumasa, primary

Published
2023
Full Text
View/download PDF

38. Supplementary Table 1 from Phase I Trial of a Glypican-3–Derived Peptide Vaccine for Advanced Hepatocellular Carcinoma: Immunologic Evidence and Potential for Improving Overall Survival

Author

Sawada, Yu, primary, Yoshikawa, Toshiaki, primary, Nobuoka, Daisuke, primary, Shirakawa, Hirofumi, primary, Kuronuma, Toshimitsu, primary, Motomura, Yutaka, primary, Mizuno, Shoichi, primary, Ishii, Hiroshi, primary, Nakachi, Kohei, primary, Konishi, Masaru, primary, Nakagohri, Toshio, primary, Takahashi, Shinichiro, primary, Gotohda, Naoto, primary, Takayama, Tadatoshi, primary, Yamao, Kenji, primary, Uesaka, Katsuhiko, primary, Furuse, Junji, primary, Kinoshita, Taira, primary, and Nakatsura, Tetsuya, primary

Published
2023
Full Text
View/download PDF

39. Abstract CT010: Primary results of phase 2 FOENIX-CCA2: The irreversible FGFR1-4 inhibitor futibatinib in intrahepatic cholangiocarcinoma (iCCA) with FGFR2 fusions/rearrangements

Author

Goyal, Lipika, primary, Meric-Bernstam, Funda, additional, Hollebecque, Antoine, additional, Morizane, Chigusa, additional, Valle, Juan W., additional, Karasic, Thomas B., additional, Abrams, Thomas A., additional, Kelley, Robin Kate, additional, Cassier, Philippe, additional, Furuse, Junji, additional, Klümpen, Heinz-Josef, additional, Chang, Heung-Moon, additional, Chen, Li-Tzong, additional, Komatsu, Yoshito, additional, Masuda, Kunihiro, additional, Ahn, Daniel, additional, He, Yaohua, additional, Soni, Nital, additional, Benhadji, Karim A., additional, and Bridgewater, John A., additional

Published
2021
Full Text
View/download PDF

40. Abstract CT283: KEYNOTE-966: A randomized, double-blind, placebo-controlled, phase 3 study of pembrolizumab in combination with gemcitabine and cisplatin for the treatment of advanced biliary tract carcinoma

Author

Finn, Richard S., primary, Kelley, Robin K., additional, Furuse, Junji, additional, Edeline, Julien, additional, Ren, Zhenggang, additional, Su, Shu-Chih, additional, Malhotra, Usha, additional, Siegel, Abby B., additional, and Valle, Juan W., additional

Published
2020
Full Text
View/download PDF

41. Abstract 2675: Assessment of inflammation biomarkers in relation to clinical outcomes in nivolumab-treated patients with advanced hepatocellular carcinoma in CheckMate 040

Author

Melero, Ignacio, primary, Neely, Jaclyn, additional, Sangro, Bruno, additional, Finn, Richard, additional, Abou-Alfa, Ghassan K., additional, Cheng, Ann-Lii, additional, Yau, Thomas, additional, Furuse, Junji, additional, Park, Joong-Won, additional, Wadhawan, Samir, additional, Tang, Hao, additional, Delacruz, Christine, additional, Baccan, Carlos, additional, Boyd, Zach, additional, and El-Khoueiry, Anthony, additional

Published
2019
Full Text
View/download PDF

42. Rb Loss and KRAS Mutation Are Predictors of the Response to Platinum-Based Chemotherapy in Pancreatic Neuroendocrine Neoplasm with Grade 3: A Japanese Multicenter Pancreatic NEN-G3 Study

Author

Hijioka, Susumu, primary, Hosoda, Waki, additional, Matsuo, Keitaro, additional, Ueno, Makoto, additional, Furukawa, Masayuki, additional, Yoshitomi, Hideyuki, additional, Kobayashi, Noritoshi, additional, Ikeda, Masafumi, additional, Ito, Tetsuhide, additional, Nakamori, Shoji, additional, Ishii, Hiroshi, additional, Kodama, Yuzo, additional, Morizane, Chigusa, additional, Okusaka, Takuji, additional, Yanagimoto, Hiroaki, additional, Notohara, Kenji, additional, Taguchi, Hiroki, additional, Kitano, Masayuki, additional, Yane, Kei, additional, Maguchi, Hiroyuki, additional, Tsuchiya, Yoshiaki, additional, Komoto, Izumi, additional, Tanaka, Hiroki, additional, Tsuji, Akihito, additional, Hashigo, Syunpei, additional, Kawaguchi, Yoshiaki, additional, Mine, Tetsuya, additional, Kanno, Atsushi, additional, Murohisa, Go, additional, Miyabe, Katsuyuki, additional, Takagi, Tadayuki, additional, Matayoshi, Nobutaka, additional, Yoshida, Tsukasa, additional, Hara, Kazuo, additional, Imamura, Masayuki, additional, Furuse, Junji, additional, Yatabe, Yasushi, additional, and Mizuno, Nobumasa, additional

Published
2017
Full Text
View/download PDF

43. Abstract A165: Result of a phase 1 (dose-escalation stage), first-in-human study of ASP5878, an oral FGFR inhibitor, in patients with advanced solid tumors

Author

Shimizu, Toshio, primary, Doi, Toshihiko, additional, Yamamoto, Noboru, additional, Murakami, Haruyasu, additional, Furuse, Junji, additional, Kawai, Koji, additional, Nishiyama, Hiroyuki, additional, Morita, Satoshi, additional, Takahashi, Shunji, additional, Bahceci, Erkut, additional, Steinberg, Joyce, additional, Ball, Howard A., additional, Kunieda, Futoshi, additional, Takeda, Kentaro, additional, Kita, Aya, additional, and Takeshita, Shigeru, additional

Published
2015
Full Text
View/download PDF

44. Phase I Trial of a Glypican-3–Derived Peptide Vaccine for Advanced Hepatocellular Carcinoma: Immunologic Evidence and Potential for Improving Overall Survival

Author

Sawada, Yu, primary, Yoshikawa, Toshiaki, additional, Nobuoka, Daisuke, additional, Shirakawa, Hirofumi, additional, Kuronuma, Toshimitsu, additional, Motomura, Yutaka, additional, Mizuno, Shoichi, additional, Ishii, Hiroshi, additional, Nakachi, Kohei, additional, Konishi, Masaru, additional, Nakagohri, Toshio, additional, Takahashi, Shinichiro, additional, Gotohda, Naoto, additional, Takayama, Tadatoshi, additional, Yamao, Kenji, additional, Uesaka, Katsuhiko, additional, Furuse, Junji, additional, Kinoshita, Taira, additional, and Nakatsura, Tetsuya, additional

Published
2012
Full Text
View/download PDF

45. Severe Drug Toxicity Associated with a Single-Nucleotide Polymorphism of the Cytidine Deaminase Gene in a Japanese Cancer Patient Treated with Gemcitabine plus Cisplatin

Author

Yonemori, Kan, primary, Ueno, Hideki, additional, Okusaka, Takuji, additional, Yamamoto, Noboru, additional, Ikeda, Masafumi, additional, Saijo, Nagahiro, additional, Yoshida, Teruhiko, additional, Ishii, Hiroshi, additional, Furuse, Junji, additional, Sugiyama, Emiko, additional, Kim, Su-Ryang, additional, Kikura-Hanajiri, Ruri, additional, Hasegawa, Ryuichi, additional, Saito, Yoshiro, additional, Ozawa, Shogo, additional, Kaniwa, Nahoko, additional, and Sawada, Jun-ichi, additional

Published
2005
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results